Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.4619
Delayed Data
As of Jul 06
 -0.0181 / -3.77%
Today’s Change
0.40
Today|||52-Week Range
0.69
-17.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization22.5K25.8K25.2K30.0K
 
 
 
 
 
 
Operating ExpensesGross Income-22.5K-25.8K-25.2K-30.0K
 
 
 
 
 
General Expenses7.2M7.9M7.3M9.6M
 
 
 
 
 
Research And Development4.8M5.4M4.9M6.0M
 
 
 
 
 
Total Operating Expenses7.2M7.9M7.4M9.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.2M-7.9M-7.4M-9.7M
 
 
 
 
 
Extraordinary Credit10.9K--307.000.00
 
 
 
Extraordinary Charge---1.9K----
 
 
Other Expenses33.0K253.0021.9K4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.2M-7.9M-7.3M-9.6M
 
 
 
 
 
Net Income-7.2M-7.9M-7.3M-9.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS115.6M123.3M145.3M159.5M
 
 
 
 
 
Shares To Calculate EPS Diluted115.6M123.3M145.3M159.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.06-$0.05-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.05-$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account